Good summary Lightforce !, some additions to consider,
4 new patents achieved recently boosting the IP position even further, plus 11 completed clinical studies within various markets which can only consolidate the perception of the health benefits of a2 products.
Market disrupting, solid IP, high moat, high gross margins, strong forward growth.
And, substantially undervalued according to many analysts who are awaiting further risk to fall away, investors should be cognisant of those risks also though.
The New Dynamic towards ~$1.50, page-3
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.81 |
Change
-0.090(1.84%) |
Mkt cap ! $3.482B | |||
| Open | High | Low | Value | Volume |
| $4.92 | $4.95 | $4.80 | $8.716M | 1.802M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10795 | $4.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.83 | 5662 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| A2M (ASX) Chart |